Objective: To investigate the relationship between the transcription of ANRIL, P15, P14 and P16 at the same locus and the regulation mechanism of ANRIL.
Introduction
The P15-P14-P16 (INK4) gene locus is a significant genetic susceptibility locus in cancers and cardiovascular disease (1) (2) (3) . It has also been linked to a number of other pathologies, including intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma (4) (5) (6) . The results of the Cancer Genome Project showed that this locus is the most frequently deleted region in thousands of human cancer genomes (7) . While P16 genetic deletions do occur in cancers, the frequency of P16 DNA methylation is three times that of deletions (8, 9) . P15, P14 and P16 genes coordinately control the G1→S transition in the cell cycle through the cyclin-dependent kinase (CDK) 2/4/6-cyclin D1/E-Rb pathway (10) . Higher-order chromatin structure analysis showed that the P15-P14-P16 chromatin presents in a dynamic compact loop for coordinate repression of these genes through CTCF-binding and that the chromatin decompaction leads to activation of these genes (11, 12) .
LncRNA ANRIL (CDKN2B-AS1) is transcribed from the antisense-strand of the P14 promoter and P15 gene regions in the INK4 locus (chr9: 21,994,791-22,120,544 in the hg19 human assembly) (13, 14) . The preliminary ANRIL transcripts are spliced into various mature forms (Supplementary Figure S1) (6, 15) . It was reported that ANRIL and miR31HG might downregulate P15 and P16 transcription through interacting with components of polycomb repressive complex-1 or -2 (PRC-1/-2) (16) (17) (18) (19) . However, the transcriptional relationship between these genes within the INK4 locus has not been well studied. The regulatory mechanism of ANRIL transcription has rarely been reported (20) . In the present study, we report that P16 DNA methylation may repress ANRIL transcription. Bioinformatics and experimental analysis support that ANRIL and P16 are coordinately transcribed in human cells.
Materials and methods

Patients tissue collection
Colon carcinoma along with paired non-cancerous surgical margin samples were collected from 76 patients at the Peking University Cancer Hospital from 2009 to 2011. The Ethics Committee of Peking University Cancer Hospital approved this study. All patients provided written informed consent to participate in the study. The authors had no access to information that could identify individual participants during or after data collection.
Database sources
Gene expression and copy number of 995 cancer cell lines was downloaded from the publicly available database [https://portals.broadinstitute.org/ccle/home] of the BroadNovartis Cancer Cell Line Encyclopedia (CCLE) (21).
Cell lines and culture
Human cell lines BGC823, MGC803, RKO, H1299, GES1 and SGC7901 were cultured in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS). The human cell lines Caski, Colo205, HeLa, MHCC97H, Siha and SW480 were cultured in Dulbecco's modified eagle medium (DMEM) with 10% FBS. AGS and PC3 were cultured in F12 medium with 10% FBS. All of these cell lines were cultured at 37 °C in 5% CO 2 . PC3 cell line was purchased from Cell Line Bank, Chinese Academy of Medical Science. RKO cell line was kindly provided by Dr.
Guoren Deng at University of California San Francisco, and SW480 cell line, by Dr. Yuanjia Chen at Peking Union Medical College Hospital. AGS (from Dr. Chengchao Shou), GES1, BGC823, SGC7901, HeLa, Caski, Siha, H1299, Colo205 and MHCC97H cell lines (from Dr. Yang Ke) were obtained from laboratories at Peking University Cancer Hospital/Institute.
RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR)
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These cells were harvested when the density reached about 70%. Total RNA was extracted by TRIzol (Invitrogen) and reverse-transcribed using a first-cDNA synthesis kit (Transgen). The expression levels of the ANRIL, P16, P15 and P14 genes were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) using the corresponding primer sets ( Table 1) . To detect the linear ANRIL (NR_003529) expression status in cell lines and tissues, primer sets E3-E4 and E1-E2 were used for qRT-PCR and RT-PCR, respectively. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a reference gene. Power SYBR Green PCR Master Mix (Fermentas) was used in qRT-PCR (ABI-7500). Relative mRNA level was calculated based on the average Ct value of the target gene and the GAPDH reference [ ].
Transfection and construction of vectors
P16-specific siRNAs (5'-ccguaaauguccauuuauatt-3' and 5'-uauaaauggacauuuacggtt-3') were synthesized in GenePharma (Shanghai) and used to transiently transfect cells at a final concentration of 1.0 μg/mL. The negative control was scramble siRNAs (5'-uucuccgaacgugucacgutt-3' and 5'-acgugacacguucggagaatt-3') (GenePharma, Shanghai). The P16 expression vector was constructed by integrating the wild-type P16 cDNA into the pIRES2-EGFP vector. A total of 4.5×10 4 cells were transiently transfected with the pIRES2-P16 expression vector, seeded into each well (diameter, 3.48 cm; 6-well microplate; 3 wells/group), and incubated for 48 h. The P16-Dnmt_pTRIPZ and P16-ATF_pcDNA3.1 vectors were constructed as described previously (22, 23) . These experiments were repeated 2-3 times.
Detection of P16 and P14 methylation by denaturing high performance liquid chromatography (DHPLC)
The methylation status of the P16 and P14 CpG islands was determined using DHPLC as previously described (22, 24, 25) .
Western blotting
Protein extracts were equally loaded into 12% acrylamide gels, electrophoresed, and transferred to PVDF membranes (Millipore). After blocking with 5% fat-free milk in PBS, the membranes were probed with rabbit anti-P16 (Ab50282; Abcam) and mouse anti-GAPDH (60004-1-Ig; Proteintech) which were diluted at 1:3,000 and 1:10,000, respectively. After incubation at room temperature for 1 h, membranes were washed with PBST three times, and incubated with horse radish peroxidase (HRP)-labeled secondary antibody goat anti-rabbit IgG (1:5,000) and antimouse IgG (1:10,000), respectively. Signals were visualized using the Enhanced Chemiluminescence kit (Pierce).
Statistical analysis
All statistical analyses were performed using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA). Student's t-test was conducted for normally distributed data. The significance of gene expression associations (r) was statistically tested with adjusting gene copy number, and P<0.05 was considered statistically significant.
Results
Transcription of ANRIL is significantly correlated with P16 expression
In order to investigate the relationship between transcription levels of the genes within the INK4 locus, we analyzed the publicly available databases in the CCLE project (21). The INK4 locus is absent from 298 cell lines [copy number value (CN) <-2.0] and is present in 713 cell lines (Supplementary File S1). Because the 298 INK4 locusabsent cell lines cannot express the locus genes ( Figure 1A) , only the INK4 allele-containing cell lines were used in the correlation analysis. Unexpectedly, we found that the transcription level of ANRIL was positively and significantly correlated with the transcription level of P16 in the 713 cell lines (r s =0.254, P<0.001), but was not correlated with transcription levels of P15 (r s =-0.015, P=0.701), although the P16 and P15 expression levels were correlated with each other ( Figure 1B ). P16 mRNA levels were still positively correlated with the ANRIL expression levels after the gene copy number was adjusted (P<0.001). Among 224 cell lines without the INK4 locus deletion (CN>0.0), the same phenomenon was consistently observed ( Figure 1C ). These results indicated that ANRIL is coordinately transcribed with P16 but not with P15. To confirm these correlations, we analyzed the transcription levels of ANRIL, P16, P15 and P14 genes in a panel of cell lines without the INK4 deletion using qRT-PCR, and observed the same phenomena. As expected, high level of ANRIL transcription was only observed in the P16-unmethylated cell lines (Caski, SGC7901, BGC823, GES1, Siha and HeLa), but not in P16-methylated cell lines (Colo205, PC3, MHCC97H, RKO, SW480 and AGS) (Figure 2A, 3A, 3B) . P16 mRNA expression level was closely correlated with ANRIL expression level (r=0.774, P=0.003), suggesting that P16 DNA methylation might repress transcription of ANRIL. Such an association was not observed between the ANRIL level and the P15 or P14 mRNA levels (r=0.090 or 0.297, P=0.780 or 0.349) ( Figure 3C, D) .
The positive relationship between the ANRIL and P16 expression levels was further validated in human colon tissue samples. As expected, the ANRIL expression level was significantly increased in colon cancer tissues compared to corresponding non-cancerous surgical margins [χ 2 test, 19/76 (25.0%) vs. 2/76 (2.6%), P<0.001]. No significant association was observed between the ANRIL lncRNA expression level and pTNM stage or other clinicopathological characteristics or overall survival of colon cancer patients (data not shown). Notably, the P16 mRNA level was significantly higher in the ANRIL-positive samples than in the ANRIL-negative samples (P<0.001; Figure 4A ). Once again, the P15 mRNA expression level was similar to the ANRIL-positive samples compared to the ANRILnegative samples (P=0.879; Figure 4B ). These results indicated that ANRIL and P16 genes are coordinately transcribed in human cells.
Interestingly, the CpG islands around the P14 transcription start site were methylated only in the AGS and RKO cells but not in the remaining cells ( Figure 2B ). Because the number of the P14-methylated cell lines is limited, an association between ANRIL transcription and P14 methylation was not observed.
Transcription repression of ANRIL by P16 DNA methylation
Recently, we constructed a P16 promoter DNA methyltransferase (P16-Dnmt) that can specifically methylate P16 CpG islands around transcription start sites, and this subsequently leads to silencing of P16 transcription in human cells but cannot induce P14 methylation or P14 repression (20). To elucidate whether methylation of P16 CpG islands directly leads to the silencing of ANRIL transcription, we analyzed the transcription level of ANRIL in GES1 and BGC823 cells, in which P16 CpG islands were methylated by the stably transfected P16-Dnmt_pTRIPZ vector with induction of 0.25 μg/mL doxycycline for 14 days ( Figure 5A, C) . qRT-PCR analysis showed that the transcriptional activities of both P16 and ANRIL were significantly decreased, whereas the P15 mRNA expression level was not changed, and the P14 mRNA expression level was slightly increased ( Figure 5B, D) in these cell lines.
By contrast, using a P16-specific artificial transcription factor (P16-ATF) that can induce demethylation of P16 CpG islands and reactivate gene expression ( Figure 5E ) (23), we found that transcriptional activities of both P16 and ANRIL were significantly increased (P<0.001), whereas P15 and P14 mRNA expression levels were not changed in H1299 cells that were stably transfected with the P16-ATF_pcDNA3.1 vector ( Figure 5F ). These results demonstrated that P16 DNA methylation indeed represses ANRIL transcription.
Transcription of ANRIL is not affected by changes in P16 expression
To clarify whether downregulation of ANRIL expression is directly caused by P16 DNA methylation itself or indirectly caused by subsequent P16 repression, we induced P16 expression changes in H1299 and BGC823 cells through transient transfection, and found that the ANRIL level remained stable following P16 overexpression and siRNA knockdown ( Figures 6A, B) , respectively. Similar result was also obtained in MGC803 cells ( Figure 6C ). These data suggest that it is P16 methylation itself, but not P16 downregulation, that leads to the repression of ANRIL transcription. 
Discussion
ANRIL is transcribed from the INK4 locus and can be spliced into diverse mature forms to regulate gene transcription in the nucleus and to interact with proteins in the cytoplasm (6, 15) . Consistent with others' reports that ANRIL is upregulated in many cancers (26-32), we find that ANRIL is also significantly upregulated in colon cancer. The mechanisms of regulation of ANRIL transcription have rarely been reported (20). In the present study, we report that the endogenous ANRIL and P16 genes are coordinately transcribed in cancer cells in vitro and in vivo, and that P16 methylation may repress ANRIL transcription.
ANRIL is considered to be an oncogene, according to its frequent upregulation in many cancers and association with a poor prognosis (26-32). In the present study, we observed significant ANRIL upregulation in colon cancer tissues. There was no association between the ANRIL lncRNA expression level and prognosis of colon cancer.
There are a number of regulators that co-regulate transcription of P15, P14 and P16 (10, 17, 33) . It is reasonable to expect that ANRIL lncRNA expression correlates with that of the genes in the INK4 locus. In contrast to another report that ANRIL (CDKN2B-AS) may repress P15 expression (34), we did not observe any correlation between the expression levels of ANRIL and P15, both in a large number of cancer cell lines and in colon tissues. Interestingly, we found a strong positive relationship between the expression levels of ANRIL and P16. Our experimental evidence strongly supports that the methylation status of the P16 CpG islands directly affects the transcriptional activity of both ANRIL and P16, indicating the bi-directional functions of the P16 promoter. It was previously reported that P16 methylation was associated with loss of CTCF binding and a chromatin boundary in the P16 gene (11) . The INK4 chromatin is enriched with the CTCF binding sites and CTCF depletion disrupts the INK4 chromatin loop formation (12) . P16 methylation may repress ANRIL transcription via the INK4 chromatin conformation changes.
It was reported that ANRIL downregulation by siRNA increased the P16 expression level in cancer cells (18). However, an inverse relationship between the ANRIL and P16 transcription levels was not observed in 224 cancer cell lines without P16 allele deletion and colon cancer tissues from 76 patients. Instead, higher P16 mRNA expression was detected in cell lines and tissues with ANRIL expression than those without ANRIL expression. Endogenous ANRIL and P16 expression levels are positively correlated with each other in vitro and in vivo.
P16 is a weakly expressed nucleic protein that inhibits CDK4 activity in normal human cells (1) . Although P16 expression is epigenetically repressed in approximately 30%-40% of cancers (8,9,35-38), strong cytoplasmic P16 staining could be detected in some cancers, especially in the human papillomavirus (HPV) infection-related cancers (i.e., cervical, oral, skin and thyroid cancers) (39-42). Interestingly, according to the publicly available database in the Human Protein Atlas project, the majority of P16 proteins are incorrectly located in the cytoplasm of P16 staining-positive cancer cells from multiple cancer types (i.e., breast, colon, gliocyte, liver, lung, melanocyte, ovarian, prostate, stomach, and urothelial tract), where HPV infection has not been reported (Supplementary Figure S2) 
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